Résultats de recherche
Daniel Joshua Drucker (né le 23 juin 1956) est un endocrinologue canadien. Membre de la Royal Society 1, il est professeur de médecine au Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto.
Dr. Drucker is a leading researcher in the field of glucagon-like peptides and their receptors. He holds a Canada Research Chair and a Novo Nordisk Chair in Incretin Biology at Mount Sinai Hospital in Toronto.
Daniel Joshua Drucker (born 23 June 1956) is a Canadian endocrinologist. A Fellow of the Royal Society, he is a professor of medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto.
Dr. Drucker is a clinician-scientist who studies peptide hormones that regulate metabolism and develops treatments for diabetes, obesity and intestinal disorders. He holds several prestigious awards and chairs for his research on glucagon-like peptides and their analogues.
Chercheur de laboratoire exceptionnellement doué, le D r Drucker, a personnellement procédé à transposer des découvertes scientifiques avancées au contexte d’applications cliniques réelles, améliorant considérablement la vie des patients.
Dr. Drucker is a clinical-scientist who discovered the actions of GLP-1 and GLP-2, leading to new medications for diabetes, obesity and short bowel syndrome. He is a Professor of Medicine at the University of Toronto and a member of the National Academy of Sciences.
Abstract. Incretin hormones, principally glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), potentiate meal-stimulated insulin secretion through direct (GIP + GLP-1) and indirect (GLP-1) actions on islet β-cells.
Find Their Age, Phone Number & Address. See Their Online Pics And Profiles.
